HomeGERN • NASDAQ
add
Geron Corp
Previous close
$3.42
Day range
$3.15 - $3.45
Year range
$1.64 - $5.34
Market cap
1.92B USD
Avg Volume
10.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 28.27M | 17,138.41% |
Operating expense | 35.88M | 95.51% |
Net income | -26.45M | 40.97% |
Net profit margin | -93.55 | 99.66% |
Earnings per share | -0.04 | 50.00% |
EBITDA | -28.18M | 40.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 339.77M | 8.37% |
Total assets | 444.95M | 7.73% |
Total liabilities | 152.67M | 24.72% |
Total equity | 292.28M | — |
Shares outstanding | 604.50M | — |
Price to book | 7.12 | — |
Return on assets | -15.77% | — |
Return on capital | -18.24% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -26.45M | 40.97% |
Cash from operations | -58.94M | -15.94% |
Cash from investing | -554.00K | 88.25% |
Cash from financing | 3.58M | -87.81% |
Net change in cash | -55.87M | -113.30% |
Free cash flow | -50.01M | -48.27% |
About
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
Founded
1990
Headquarters
Website
Employees
141
